Cargando…

Identification, and Experimental and Bioinformatics Validation of an Immune-Related Prognosis Gene Signature for Low-Grade Glioma Based on mRNAsi

SIMPLE SUMMARY: In this study; four immune-related predictive biomarkers for LGG were identified and proven to be IRGs. The development of more efficient immunotherapy techniques was facilitated by the creation of a prognostic signature to evaluate and forecast the prognosis of LGG patients. The imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuan, Ye, Shengda, Wu, Du, Xu, Ziyue, Wei, Wei, Duan, Faliang, Luo, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296549/ https://www.ncbi.nlm.nih.gov/pubmed/37370848 http://dx.doi.org/10.3390/cancers15123238

Ejemplares similares

Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma
por: Huang, Haifu, et al.
Publicado: (2023)

Prognostic Value of mRNAsi/Corrected mRNAsi Calculated by the One-Class Logistic Regression Machine-Learning Algorithm in Glioblastoma Within Multiple Datasets
por: Zhang, Mingwei, et al.
Publicado: (2021)

Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer
por: Zhao, Xugui, et al.
Publicado: (2022)

mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers
por: Zhang, Yitong, et al.
Publicado: (2020)

Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma
por: Li, Zhe, et al.
Publicado: (2023)

An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma
por: Tang, Guihua, et al.
Publicado: (2023)

mRNAsi-related genes can effectively distinguish hepatocellular carcinoma into new molecular subtypes
por: Wang, Canbiao, et al.
Publicado: (2022)

Identifying 8-mRNAsi Based Signature for Predicting Survival in Patients With Head and Neck Squamous Cell Carcinoma via Machine Learning
por: Tian, Yuxi, et al.
Publicado: (2020)

Identification of Prognostic Markers and Potential Therapeutic Targets in Gastric Adenocarcinoma by Machine Learning Based on mRNAsi Index
por: Guo, Si Hong, et al.
Publicado: (2022)

Analyzing mRNAsi-Related Genes Identifies Novel Prognostic Markers and Potential Drug Combination for Patients with Basal Breast Cancer
por: Huang, Kai, et al.
Publicado: (2021)

mRNAsi-related metabolic risk score model identifies poor prognosis, immunoevasive contexture, and low chemotherapy response in colorectal cancer patients through machine learning
por: Weng, Meilin, et al.
Publicado: (2022)

Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses
por: Ye, Shengda, et al.
Publicado: (2022)

A Bioinformatics-Based Analysis of an Anoikis-Related Gene Signature Predicts the Prognosis of Patients with Low-Grade Gliomas
por: Zhao, Songyun, et al.
Publicado: (2022)

An integrative bioinformatics investigation and experimental validation of critically involved genes in high-grade gliomas
por: Ahmadi-Beni, Reza, et al.
Publicado: (2022)

Bioinformatical analysis of gene expression signatures of different glioma subtypes
por: Wang, Rui, et al.
Publicado: (2018)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

Development and validation of an immune-related gene signature for predicting the radiosensitivity of lower-grade gliomas
por: Yan, Derui, et al.
Publicado: (2022)

Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma
por: Huang, Qian-Rong, et al.
Publicado: (2022)

Identification and validation of an autophagy-related signature for predicting survival in lower-grade glioma
por: Feng, Shaobin, et al.
Publicado: (2021)

Identification and Validation of a Seizure-Free-Related Gene Signature for Predicting Poor Prognosis in Lower-Grade Gliomas
por: Li, Jinxing, et al.
Publicado: (2021)

High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma
por: Wang, Gang, et al.
Publicado: (2022)

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma
por: Xiao, Youchao, et al.
Publicado: (2020)

Identification and validation of a 9-gene signature for the prognosis of ovarian cancer by integrated bioinformatical analysis
por: Chen, Siping, et al.
Publicado: (2022)

Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma
por: Zhao, Jingwei, et al.
Publicado: (2020)

A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma
por: Liu, Wentao, et al.
Publicado: (2021)

A Metabolic Plasticity-Based Signature for Molecular Classification and Prognosis of Lower-Grade Glioma
por: Yang, Ming-Chun, et al.
Publicado: (2022)

Microglia-Based Gene Expression Signature Highly Associated with Prognosis in Low-Grade Glioma
por: Schaafsma, Evelien, et al.
Publicado: (2022)

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
por: Cai, Jiayang, et al.
Publicado: (2022)

A Bioinformatic Analysis: The Overexpression and Prognostic Potential of GPX7 in Lower-Grade Glioma
por: Zhao, Qianqian, et al.
Publicado: (2022)

Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment
por: Li, Yong, et al.
Publicado: (2020)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas
por: Zhao, Xu, et al.
Publicado: (2022)

A Novel TNFSF-Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower-Grade Glioma
por: Tao, Rui, et al.
Publicado: (2022)

Basement-Membrane-Related Gene Signature Predicts Prognosis in WHO Grade II/III Gliomas
por: Zhang, Zhaogang, et al.
Publicado: (2022)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022)

A gene signature predicting prognosis of patients with lower-grade gliomas receiving temozolomide therapy
por: Wan, Yanzhi, et al.
Publicado: (2023)

Development and Validation of an Immune-Related Gene Pairs Signature in Grade II/III Glioma
por: Zhang, Xu, et al.
Publicado: (2021)

Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas
por: Bao, Jia-hao, et al.
Publicado: (2022)

Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas
por: Du, Wei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mei5unpdb189sqajq9riflhlp1